AIRLINK 176.89 Decreased By ▼ -2.72 (-1.51%)
BOP 11.35 Decreased By ▼ -0.17 (-1.48%)
CNERGY 7.94 Decreased By ▼ -0.04 (-0.5%)
FCCL 45.41 Decreased By ▼ -1.21 (-2.6%)
FFL 16.32 Decreased By ▼ -0.29 (-1.75%)
FLYNG 27.85 Decreased By ▼ -0.73 (-2.55%)
HUBC 138.98 Decreased By ▼ -2.09 (-1.48%)
HUMNL 13.20 Increased By ▲ 0.05 (0.38%)
KEL 4.41 Decreased By ▼ -0.10 (-2.22%)
KOSM 6.14 Decreased By ▼ -0.11 (-1.76%)
MLCF 58.86 Decreased By ▼ -0.54 (-0.91%)
OGDC 218.17 Decreased By ▼ -9.18 (-4.04%)
PACE 5.97 Increased By ▲ 0.01 (0.17%)
PAEL 45.87 Decreased By ▼ -2.31 (-4.79%)
PIAHCLA 18.23 Decreased By ▼ -0.16 (-0.87%)
PIBTL 10.55 Increased By ▲ 0.08 (0.76%)
POWER 11.51 Decreased By ▼ -0.02 (-0.17%)
PPL 184.50 Decreased By ▼ -6.88 (-3.59%)
PRL 37.04 Decreased By ▼ -1.10 (-2.88%)
PTC 24.08 Decreased By ▼ -0.23 (-0.95%)
SEARL 97.66 Decreased By ▼ -2.30 (-2.3%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 37.32 Decreased By ▼ -0.70 (-1.84%)
SYM 15.34 Decreased By ▼ -0.10 (-0.65%)
TELE 7.87 Decreased By ▼ -0.14 (-1.75%)
TPLP 11.11 Increased By ▲ 0.01 (0.09%)
TRG 70.20 Increased By ▲ 1.99 (2.92%)
WAVESAPP 11.10 Decreased By ▼ -0.06 (-0.54%)
WTL 1.38 Decreased By ▼ -0.02 (-1.43%)
YOUW 3.82 Decreased By ▼ -0.11 (-2.8%)
AIRLINK 176.89 Decreased By ▼ -2.72 (-1.51%)
BOP 11.35 Decreased By ▼ -0.17 (-1.48%)
CNERGY 7.94 Decreased By ▼ -0.04 (-0.5%)
FCCL 45.41 Decreased By ▼ -1.21 (-2.6%)
FFL 16.32 Decreased By ▼ -0.29 (-1.75%)
FLYNG 27.85 Decreased By ▼ -0.73 (-2.55%)
HUBC 138.98 Decreased By ▼ -2.09 (-1.48%)
HUMNL 13.20 Increased By ▲ 0.05 (0.38%)
KEL 4.41 Decreased By ▼ -0.10 (-2.22%)
KOSM 6.14 Decreased By ▼ -0.11 (-1.76%)
MLCF 58.86 Decreased By ▼ -0.54 (-0.91%)
OGDC 218.17 Decreased By ▼ -9.18 (-4.04%)
PACE 5.97 Increased By ▲ 0.01 (0.17%)
PAEL 45.87 Decreased By ▼ -2.31 (-4.79%)
PIAHCLA 18.23 Decreased By ▼ -0.16 (-0.87%)
PIBTL 10.55 Increased By ▲ 0.08 (0.76%)
POWER 11.51 Decreased By ▼ -0.02 (-0.17%)
PPL 184.50 Decreased By ▼ -6.88 (-3.59%)
PRL 37.04 Decreased By ▼ -1.10 (-2.88%)
PTC 24.08 Decreased By ▼ -0.23 (-0.95%)
SEARL 97.66 Decreased By ▼ -2.30 (-2.3%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 37.32 Decreased By ▼ -0.70 (-1.84%)
SYM 15.34 Decreased By ▼ -0.10 (-0.65%)
TELE 7.87 Decreased By ▼ -0.14 (-1.75%)
TPLP 11.11 Increased By ▲ 0.01 (0.09%)
TRG 70.20 Increased By ▲ 1.99 (2.92%)
WAVESAPP 11.10 Decreased By ▼ -0.06 (-0.54%)
WTL 1.38 Decreased By ▼ -0.02 (-1.43%)
YOUW 3.82 Decreased By ▼ -0.11 (-2.8%)
BR100 12,354 Decreased By -242.4 (-1.92%)
BR30 38,124 Decreased By -1009.1 (-2.58%)
KSE100 116,440 Decreased By -2002.6 (-1.69%)
KSE30 35,703 Decreased By -672.5 (-1.85%)

NEW YORK: Canadian singer Grimes put the word out Monday that she is fine with her voice being used for AI-generated songs, as long as she gets half the royalties.

The 35-year-old songwriter, producer and performer said in an Instagram post that she would treat an artificial intelligence hit using her voice as she would a collaboration with any artist.

“Feel free to use my voice without penalty,” Grimes said in a post on her verified Instagram account.

“I’ll split 50 percent royalties on any successful AI generated song that uses my voice.”

Grimes added that she has no obligations to a recording label so can uphold the offer.

The singer’s post contained a reference to news about AI being used to imitate Canadian singers Drake and The Weeknd.

The viral song released last Friday, ‘Heart On My Sleeve’ was briefly available on platforms including Spotify and Apple Music before Universal Music Group – which publishes both artists through a subsidiary – said it violated copyrights and asked for its removal.

The use of AI in music is the subject of debate in the industry, with some denouncing copyright abuses and others praising its prowess.

Steadily improving generative AI from OpenAI has fueled debate about whether the software respects intellectual property.

Grimes is a former partner of Tesla chief Elon Musk, with whom she had two children, including one by surrogate mother.

Musk has called AI a threat to humanity while simultaneously investing in the technology.

Comments

Comments are closed.